IP Library Granted Patent US 9,074,104
Granted Patent B2
US 9,074,104 · App. 14/018,334 · Granted Jul 7, 2015

Inks comprising amorphous ureas

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,074,104
App. No.
14/018,334
Granted
Jul 7, 2015
Kind
B2
Abstract

A phase change ink includes a crystalline component and an amorphous component, the amorphous component including a branched alkyl core and a urea functional group.

Claims (32)

1. A phase change ink comprising:

a crystalline component; and

an amorphous component, wherein the amorphous component comprises a branched alkyl core and a urea functional group.

2. The phase change ink of claim 1 , wherein a ratio of the crystalline component to amorphous components ranges from about 9:1 to about 2:1.

3. The phase change ink of claim 1 , wherein the amorphous component comprises a compound of formula I:

wherein each R is independently selected from a C 1 to C 6 branched or straight chain alkyl.

4. The phase change ink of claim 3 , wherein the compound of formula I is a subgenus of formula II:

wherein m and n are the integers 0 or 1, provided that both m and n are not both 0;

p is an integer from 2 to 8; and

each occurrence of A and B are independently selected from the group consisting of hydrogen, methyl, and ethyl, provided that at least one occurrence of A or B is not hydrogen.

5. The phase change ink of claim 4 , wherein the compound of formula II is a subgenus of formula III:

wherein p is an integer from 4 to 6.

6. The phase change ink of claim 5 , wherein each R is isoamyl.

7. The phase change ink of claim 5 , wherein each R is tert-pentyl.

8. The phase change ink of claim 5 , wherein each R is n-butyl.

9. The phase change ink of claim 5 , wherein each R is n-propyl.

10. The phase change in of claim 5 , wherein each R is sec-butyl.

11. A phase change ink comprising:

a crystalline component; and

a urea component, wherein the urea component comprises a branched alkyl core and a urea functional group, wherein a degree of branching of the branched alkyl core is sufficient to provide the urea component that is amorphous.

12. The phase change ink of claim 11 , wherein the urea component comprises two urea functional groups.

13. The phase change ink of claim 11 , wherein the urea component comprises a compound of formula IV/IV′:

wherein each R is independently selected from a C 1 to C 6 branched or straight chain alkyl.

14. The phase change ink of claim 13 , wherein each R is isoamyl.

15. The phase change ink of claim 13 , wherein each R is n-propyl.

16. A phase change ink comprising:

a crystalline component; and

an amorphous component, wherein the amorphous component comprises a branched alkyl core and a urea functional group and wherein the amorphous component has a glass transition temperature in a range from about −15° C. to about 30° C.

17. The phase change ink of claim 16 , wherein the amorphous component comprises a compound of formula IV/IV′:

wherein each R is independently selected from a C 1 to C 6 branched or straight chain alkyl.

18. The phase change ink of claim 17 , wherein each R is isoamyl.

19. The phase change ink of claim 17 , wherein each R is n-propyl.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
RELEASE OF SECURITY INTEREST IN PATENTS AT R/F 062740/0214 Recorded May 18, 2023
From: CITIBANK, N.A., AS AGENT
To: XEROX CORPORATION
Reel/Frame 063694/0122 →
SECURITY INTEREST Recorded Nov 10, 2022
From: XEROX CORPORATION
To: CITIBANK, N.A., AS AGENT
Reel/Frame 062740/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2013
From: CHOPRA, NAVEEN; GOREDEMA, ADELA; BAMSEY, NATHAN M.; ABRAHAM, BIBY; IFTIME, GABRIEL
To: XEROX CORPORATION
Reel/Frame 031138/0264 →